Clinical Trial Update: Guselkumab Immunogenetics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for guselkumab investigating immunogenetics in psoriasis, including guttate and plaque psoriasis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guttate Psoriasis
• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Psoriasis Guttate, Plaque Psoriasis | Phase 4 | Status: ACTIVE_NOT_RECRUITING